Galderma launches ALASTIN Restorative Eye Complex with TriHex+™, bringing new science-backed innovation to the entire eye area Press release
Galderma delivers net sales of 4.765 B USD in the first nine months, up 25.1% at constant currency year-on-year, and raises full-year net sales guidance Press release
PeDRA 2026: Nemolizumab phase II data show long-term symptom relief for children aged 2 to 11 years with moderate-to-severe atopic dermatitis Press release
Galderma signs agreement to acquire ZO Skin Health, strengthening its physician-dispensed skincare offering Press release
New Galderma research reveals more than half of women mistake menopause-related skin changes for signs of ageing Press release
Fall Clinical 2026: Galderma presents new three-year Nemluvio® data showing deep and lasting skin lesion and itch responses in patients with atopic dermatitis aged 12 and older Press release
30 years of Restylane®: reshaping the aesthetics field through science-led, patient-centric innovation Press release
